FLGT Form 4: CFO Paul Kim withholds 670 shares at $21.77

Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc. (FLGT) reported a routine disposition on 08/23/2025 in which 670 shares of common stock were disposed (transaction code F) at a price of $21.77 per share.

Rhea-AI Filing Summary

Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc. (FLGT) reported a routine disposition on 08/23/2025 in which 670 shares of common stock were disposed (transaction code F) at a price of $21.77 per share. The filing explains these shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 23, 2023. After the withholding, the reporting person beneficially owned 339,158 shares directly. The Form 4 is signed by Paul Kim on 08/26/2025.

Positive

• Transaction is routine tax withholding tied to RSU vesting rather than an open-market sale
• Significant remaining direct ownership: reporting person holds 339,158 shares after the withholding

Negative

• None.

Insights

Financial Analyst

TL;DR: A small, routine tax-withholding disposition of 670 shares; reporting officer still holds substantial equity.

The reported transaction is a standard withholding to cover taxes on vested restricted stock units rather than an open-market sale aimed at liquidity. The disposed amount (670 shares at $21.77) is minor relative to the remaining direct holdings of 339,158 shares, so the event is unlikely to materially affect company ownership structure or signal a change in executive conviction. Transaction code F and the explanatory note confirm the withholding nature, which is common following RSU vesting.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 requirements and includes appropriate explanatory note about tax withholding.

The Form 4 includes the required details: reporting person identity, relationship to issuer (CFO and Treasurer), transaction date, price, and post-transaction beneficial ownership. The explanatory footnote ties the disposition to RSU vesting originally reported on February 27, 2023, which aids transparency. The timely filing and manual signature dated 08/26/2025 meet procedural expectations for insider reporting.

Insider Trade Summary

Exercise Price or Tax Liability: 670 shares

Exercise Price or Tax Liability 1 txn

Insider Kim Paul

Role CFO and Treasurer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	670	$21.77	$15K

Holdings After Transaction: Common Stock — 339,158 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did FLGT insider Paul Kim report on Form 4?

The filing reports a disposition of 670 common shares on 08/23/2025 at $21.77 per share (transaction code F).

Why were the 670 shares disposed according to the Form 4?

The shares were withheld to satisfy tax withholding obligations from the vesting of restricted stock units granted on February 23, 2023.

How many FLGT shares does Paul Kim beneficially own after the transaction?

After the reported withholding, Paul Kim beneficially owns 339,158 shares directly.

What is Paul Kim's role at Fulgent Genetics as listed on the Form 4?

The Form 4 lists Paul Kim as a Director and as an Officer (CFO and Treasurer) of Fulgent Genetics, Inc.

When was the Form 4 signed by the reporting person?

The Form 4 is signed by Paul Kim on 08/26/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/26/2025 - 07:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Paul

(Last) (First) (Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE CA 91731

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
08/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/23/2025		F		670(1)	D	$21.77	339,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

	/s/ Paul Kim	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.